Index and targeted community-based testing to optimize HIV case finding and ART linkage among men in Zambia.


Journal

Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566

Informations de publication

Date de publication:
06 2020
Historique:
received: 20 09 2019
revised: 23 04 2020
accepted: 24 04 2020
entrez: 27 6 2020
pubmed: 27 6 2020
medline: 7 4 2021
Statut: ppublish

Résumé

Current healthcare systems fail to provide adequate HIV services to men. In Zambia, 25% of adult men living with HIV were unaware of their HIV status in 2018, and 12% of those who were unaware of their HIV statu were not receiving antiretroviral therapy (ART) due to pervasive barriers to HIV testing services (HTS) and linkage to ART. To identify men and key and priority populations living with HIV in Zambia, and link them to care and treatment, we implemented the Community Impact to Reach Key and Underserved Individuals for Treatment and Support (CIRKUITS) project. We present HTS and ART linkage results from the first year of CIRKUITS. CIRKUITS aimed to reach beneficiaries by training, mentoring, and deploying community health workers to provide index testing services and targeted community HTS. Community leaders and workplace supervisors were engaged to enable workplace HTS for men. To evaluate the effects of these interventions, we collected age- and sex-disaggregated routinely collected programme data for the first 12 months of the project (October 2018 to September 2019) across 37 CIRKUITS-supported facilities in three provinces. We performed descriptive statistics and estimated index cascades for indicators of interest, and used Chi square tests to compare indicators by age, sex, and district strata. Over 12 months, CIRKUITS tested 38,255 persons for HIV, identifying 10,974 (29%) new people living with HIV, of whom 10,239 (93%) were linked to ART. Among men, CIRKUITS tested 18,336 clients and identified 4458 (24%) as HIV positive, linked 4132 (93%) to ART. Men who tested HIV negative were referred to preventative services. Of the men found HIV positive, and 13.0% were aged 15 to 24 years, 60.3% were aged 25 to 39, 20.9% were aged 40 to 49 and 5.8% were ≥50 years old. Index testing services identified 2186 (49%) of HIV-positive men, with a positivity yield of 40% and linkage of 88%. Targeted community testing modalities accounted for 2272 (51%) of HIV-positive men identified, with positivity yield of 17% and linkage of 97%. Index testing and targeted community-based HTS are effective strategies to identify men living with HIV in Zambia. Index testing results in higher yield, but lower linkage and fewer absolute men identified compared to targeted community-based HTS.

Identifiants

pubmed: 32589360
doi: 10.1002/jia2.25520
pmc: PMC7319128
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e25520

Subventions

Organisme : CGH CDC HHS
ID : 5 NU2GGH002123-02-00
Pays : United States
Organisme : PEPFAR
Pays : United States

Informations de copyright

© 2020 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

Références

J Int AIDS Soc. 2019 Jul;22 Suppl 3:e25310
pubmed: 31321902
J Acquir Immune Defic Syndr. 2018 May 1;78(1):16-19
pubmed: 29406431
Cult Health Sex. 2020 Mar 5;:1-15
pubmed: 32133938
Cult Health Sex. 2016 Aug;18(8):936-50
pubmed: 26967538
AIDS Behav. 2017 Aug;21(8):2551-2560
pubmed: 28299518
MMWR Morb Mortal Wkly Rep. 2019 May 31;68(21):474-477
pubmed: 31145718
PLoS One. 2018 Aug 10;13(8):e0197904
pubmed: 30096139
PLoS One. 2019 Mar 21;14(3):e0211385
pubmed: 30897098
J Int AIDS Soc. 2019 Jul;22 Suppl 3:e25305
pubmed: 31321887
AIDS. 2020 May 1;34(6):923-930
pubmed: 32044842
AIDS Behav. 2015 Mar;19(3):492-504
pubmed: 25096893
PLoS One. 2019 Sep 6;14(9):e0221215
pubmed: 31490938
J Int AIDS Soc. 2019 Jul;22 Suppl 3:e25321
pubmed: 31321918
N Engl J Med. 2019 Jul 18;381(3):207-218
pubmed: 31314965
J Int AIDS Soc. 2019 Jul;22 Suppl 3:e25308
pubmed: 31321882
AIDS Care. 2016;28 Suppl 3:67-73
pubmed: 27421053
PLoS One. 2019 Jan 30;14(1):e0211022
pubmed: 30699160
AIDS. 2019 Feb 1;33(2):349-352
pubmed: 30557162
J Acquir Immune Defic Syndr. 2019 Aug 1;81(4):365-370
pubmed: 30973546
PLoS One. 2019 Mar 27;14(3):e0212762
pubmed: 30917167
Int J Infect Dis. 2018 Sep;74:54-60
pubmed: 30100537
AIDS Behav. 2018 Aug;22(8):2468-2479
pubmed: 29777420
Nature. 2015 Dec 3;528(7580):S77-85
pubmed: 26633769
N Engl J Med. 2019 Jul 18;381(3):219-229
pubmed: 31314966
BMC Infect Dis. 2019 Jun 6;19(1):496
pubmed: 31170921
AIDS Behav. 2019 Sep;23(Suppl 2):120-128
pubmed: 31161462
PLoS One. 2017 Oct 16;12(10):e0185740
pubmed: 29036171
AIDS. 2017 Jul 17;31(11):1555-1564
pubmed: 28471766
AIDS. 2014 Sep 10;28(14):2133-45
pubmed: 25062091
PLoS Med. 2017 Apr 11;14(4):e1002262
pubmed: 28399122
AIDS. 2017 Aug 24;31(13):1867-1876
pubmed: 28590326
N Engl J Med. 2019 Jul 18;381(3):286-288
pubmed: 31314975
Lancet HIV. 2019 Mar;6(3):e191-e200
pubmed: 30777726

Auteurs

Linah K Mwango (LK)

Maryland Global Initiatives Corporation Zambia, Lusaka, Zambia.

Kristen A Stafford (KA)

Center for International Health, Education, and Biosecurity, University of Maryland School of Medicine, Baltimore, MD, USA.
Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.

Natalia C Blanco (NC)

Center for International Health, Education, and Biosecurity, University of Maryland School of Medicine, Baltimore, MD, USA.
Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.

Marie-Claude Lavoie (MC)

Center for International Health, Education, and Biosecurity, University of Maryland School of Medicine, Baltimore, MD, USA.
Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.

Morley Mujansi (M)

Maryland Global Initiatives Corporation Zambia, Lusaka, Zambia.

Nasho Nyirongo (N)

Maryland Global Initiatives Corporation Zambia, Lusaka, Zambia.

Kalima Tembo (K)

Maryland Global Initiatives Corporation Zambia, Lusaka, Zambia.

Henry Sakala (H)

Maryland Global Initiatives Corporation Zambia, Lusaka, Zambia.

Julian Chipukuma (J)

Maryland Global Initiatives Corporation Zambia, Lusaka, Zambia.

Beauty Phiri (B)

Maryland Global Initiatives Corporation Zambia, Lusaka, Zambia.

Carol Nzangwa (C)

Maryland Global Initiatives Corporation Zambia, Lusaka, Zambia.

Susan Mwandila (S)

Maryland Global Initiatives Corporation Zambia, Lusaka, Zambia.

Kennedy C Nkwemu (KC)

U.S. Center for Disease Control and Prevention, Lusaka, Zambia.

Ahmed Saadani (A)

U.S. Center for Disease Control and Prevention, Lusaka, Zambia.

Annie Mwila (A)

U.S. Center for Disease Control and Prevention, Lusaka, Zambia.

Michael E Herce (ME)

Institute for Global Health and Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.

Cassidy W Claassen (CW)

Maryland Global Initiatives Corporation Zambia, Lusaka, Zambia.
Center for International Health, Education, and Biosecurity, University of Maryland School of Medicine, Baltimore, MD, USA.
Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH